Research Article
Effect of Educational Intervention on Adverse Drug Reporting by Physicians: A Cross-Sectional Study
Table 1
Knowledge of the physicians of both groups regarding pharmacovigilance.
| | Doctors attending CME | Doctors not attending CME |
| ADRs encountered per week | | | None | 32 | 52* | 1–5/week | 53 | 45 | 6–10/week | 13 | 2* | >10/week | 2 | 1 | Correct definition of pharmacovigilance | 58 | 24# | Health professional qualified to report ADR | | | Medical doctors | 99 | 96 | Dental doctors | 83 | 61# | Nurses | 48 | 58 | Pharmacists | 47 | 44 | Physiotherapists | 32 | 15* | All healthcare professional | 11 | 14 | Doctors aware of pharmacovigilance programme of India | 93 | 43# | Doctors aware of regional pharmacovigilance centre in HIHT | 81 | 36# | Aware of any drug banned due to ADR | 86 | 54# | Doctors not knowing the agents to be reported for the ADR | | | Vaccine | 20 | 21 | Herbal medicines | 79 | 70 | Over-the-counter drugs | 62 | 39* | Antibiotics | 4 | 15 | Topical agents | 47 | 43 |
|
|
; #.
|